|
|
Volumn 19, Issue SUPPL. 2, 2001, Pages 27-31
|
|
Using health outcomes data to inform decision-making: A pharmaceutical industry perspective
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIASTHMATIC AGENT;
ASTHMA;
BUDGET;
CLINICAL TRIAL;
CONFERENCE PAPER;
COST BENEFIT ANALYSIS;
DECISION MAKING;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG FORMULARY;
DRUG INDUSTRY;
DRUG INFORMATION;
ECONOMIC EVALUATION;
HEALTH CARE ACCESS;
HEALTH ECONOMICS;
HUMAN;
OUTCOMES RESEARCH;
PATIENT SATISFACTION;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PRODUCTIVITY;
PROSPECTIVE PRICING;
QUALITY OF LIFE;
REIMBURSEMENT;
|
|
EID: 0034788431
PISSN: 11707690
EISSN: None
Source Type: Journal
DOI: 10.2165/00019053-200119002-00005 Document Type: Conference Paper |
|
Times cited : (7)
|
|
References (20)
|
